Options MD

Overview
News
Mental Health Tech?
Product stageSegments
Go-to-Market
?
Telepsychiatry/Teletherapy Platforms
?

California-based Options MD is a virtual mental health provider that currently focuses on providing treatment options for individuals with treatment-resistant depression. Individuals undergo a screening process before being eligible for treatment, based on their depression, lifestyle, and overall health. Accepted individuals undergo therapy sessions with a psychiatrist and are prescribed treatment options, which include talk therapy, medication, transcranial magnetic stimulation, and ketamine. The platform claims to provide individuals with access to over 200 treatment options.



HQ location:
8721 Santa Monica Boulevard #147 Los Angeles CA USA
Founded year:
2020
Employees:
1-10
IPO status:
Private
Total funding:
USD 4.2 mn
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.